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Moxonidine inhibits Na7H exchange in proximal tubule cells
and cortical collecting duct
EBERHARD SCHLATTER, IEVA ANKORINA-STARK, SABINE HAXELMANS, and HELGE HOHAGE
Westfalische Wilhelms-Universität Münster, Medizinische Poliklinik, Experimentelle Nephro1ogie Mflnster, Germany
Moxonidine inhibits Na4iH exchange in proximal tubule cells and
cortical collecting duct. The imidazoline receptor agonist moxonidine has
been recently introduced as an antihypertensive therapy. Imidazoline
specific binding sites have also been found in the kidney. Moxonidine
induced natrjuresis and diuresis in clearance studies in rats. Related
substances such as various guanidinium derivatives have been shown to
inhibit Na/H exchange in several preparations. We therefore examined
whether the renal effects of moxonidine could be mediated by an
inhibition of the Na7H exchanger. Intracellular pH (pH,) was measured
microfluorimetrically with BCECF in proximal LLC-PK1 cells and in the
principal cells of rat cortical collecting ducts (CCD). In LLC-PK1 cells
moxonidine (10 rmol/liter) had no effect on the basal pH,; however, it
reduced the Na*/H± activity reversibly by 43 4% (N = 26) when the
exchanger was activated by cellular acidification. In rat CCD cells mox-
onidine slightly decreased basal pH, by 0.08 0.03 pH units (N = 12).
After acidification the recovery rate of pH was reduced with moxonidine
by 45 6% (N = 18). The effects of moxonidine could be mimicked in
both cell types by inhibitors of the Na/H exchanger (HOE 694,
amiloride). In the presence of the imidazoline receptor antagonist ida-
zoxan (10 zmol/liter) the effects of moxonidine were almost completely
inhibited. The cr2-antagonist yohimbine (10 mol/liter) did not signifi-
cantly alter the effects of moxonidine in both cell types. These data suggest
that in LLC-PK1 and in rat CCD cells, Na7H is inhibited by moxonidine
via an activation of the imidazoline receptor.
Moxonidine was originally introduced in the treatment of
hypertension as a centrally acting a2-adrenoceptor agonist [1]. It
decreased blood pressure effectively in these patients but had less
side effects, such as central sedation and mouth dryness, than the
classical a2-adrenergic compounds [11. Thereafter it was reported
that moxonidine has a much higher affinity to 11-imidazoline
preferring sites in the central nervous system than to the ct2-
adrenoceptor [2]. Thus, the hypotensive effect of moxonidine was
attributed to its activation of these 11-imidazoline preferring sites
in the central nervous system [3, 41. Furthermore, moxonidine
injected intracerebroventricularly induced diuresis and natriuresis
at concentrations below those necessary to reduce blood pressure
[4—6]. Both receptor classes (a2-adrenoceptors and imidazoline
receptors) have been identified in kidneys of different species,
including humans, with different nephron distributions 17—111.
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Among the guanidinium compounds some are much more selec-
tive for the a2-adrenoceptor (such as guanabenz), some bind
equally well to both receptors (such as clonidine), and some have
a much higher affinity to imidazoline receptor (such as mox-
onidine) [11]. The affinity of moxonidine to renal 11-imidazoline
preferring sites is approximately 600-fold higher compared to that
to the renal a2-adrenoceptors in the rat [11].
Both groups of antihypertensive drugs influence Na transport
in the kidney [5, 12]. Intrarenal infusion of moxonidine increased
urine flow rate and Na excretion independent of a2-adrenocep-
tor activation [5]. 11-imidazoline preferring sites are found along
the entire nephron [10, 13]. In the proximal tubule such imidazo-
line-guanidinium binding sites have been specifically localized to
the basolateral membrane [8, 9]. Several tubular effects have been
demonstrated for agonists of c2-adrenoceptors, including a stim-
ulation and an inhibition of the NatH exchange in the proximal
tubule [14, 15], inhibition of the effects of vasopressin on water
and Na transport in the cortical collecting duct [16, 17], and a
hyperpolarization of MDCK cells [18]. Inhibition of the Na/H
exchange by guanidinium and its derivatives was seen in chick
cardiac cells [191 and in rabbit proximal tubule cells [201.
In the present study we examined whether the highly specific
imidazoline-receptor agonist moxonidine influences the activity of
the Na/H exchanger in proximal tubule cells (LLC-PK1 cells)
and the cortical collecting duct of the rat.
METHODS
LLC-PK1 cell preparation and isolation of CDD segments
LLC-PK1 cells were kindly provided by Dr. M. Mohrmann
(Kinderklinik, Universität Freiburg, Freiburg, Germany). For this
study cells of passages 174-201 were used. Cells were kept in 50 ml
tissue culture flasks (Greiner, Frickenhausen, Germany) in Dul-
becco's modified Eagle's medium (Biochrom, Berlin, Germany)
supplemented with 0.5 mmol/liter L.-glutamine (Gibco BRL/Life
Technologies, Eggenstein, Germany), 100,000 U/liter penicillin,
100 mg/liter streptomycin (Biochrom), and 10% fetal bovine
serum (Biochrom). The cells were incubated at 37°C in an
atmosphere of 95% air plus 5% CO2. The confluent monolayers
were trypsinized after seven days with a Ca2- and Mg2tfree PBS
buffer and 0.05% trypsin-EDTA (Biochrom). For the experi-
ments, cells were seeded on glass cover slips with a diameter of 30
mm placed in a 35 mm petri dish (Greiner). Cell confluency was
reached after three to four days. The glass cover slips with the
confluent monolayers were mounted as the bottom of a perfusion
chamber on an inverted microscope (Axiovert 10; Zeiss, Jena,
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Germany) equipped with a bOX oil-immersion lens (apperture
1.3).
CCD segments were freshly isolated from kidneys of female
Wistar rats (body weight 100 to 200 g; Charles River Wiga,
Sulzfeld, Germany) using the enzymatic method customary in our
laboratory and described in detail before [21]. For the measure-
ments reported here, the originally described incubation in Ca2-
free buffer was omitted because cells did not have to be uncoupled
mechanically or electrically. Isolated CCD segments were fixed
with a glass pipette in the perfusion chamber.
The standard bath solution contained in mmol/liter: NaCl 145,
K2HPO4 1.6, KH2PO4 0.4, Ca-gluconate 1.3, MgC12 1, and
D-glucose 5; pH was adjusted to 7.4. This solution did not contain
HCO3/CO2 buffer to minimize the influence of HC03-depen-
dent transport systems on intracellular pH (pH1). CCD cells were
acidified using the NH4 prepulse technique with 20 mmol/liter
NH4C1 replacing 20 mmol/liter NaC1 [22]. LLC-PK1 cells were
acidified by the addition of 20 mmol/liter propionate to the
bathing solution again replacing 20 mmol/liter NaC1. Propionate
was used in the LLC-PK1 cells since the NH4 prepulse technique
did not reproducibly acidify these cells. Acidification after NI-I4
removal was often extremely short followed by an almost imme-
diate return to basal pH1, and thus the recovery rate could not be
analyzed accurately. All experiments were performed with a
constantly flowing bath (0.5 ml volume) with an exchange rate of
20 times per minute with solutions preheated to 37°C by a water
jacket around the inflow line. All standard chemicals used were
obtained in the highest available purity from Sigma (Deisenhofen,
Germany) and Merck (Darmstadt, Germany). 2',7'-bis-(2-car-
boxyethyl)-5-(and -6)-carboxyfluorescein acetoxy-methyl ester
(BCECF-AM) was obtained from Molecular Probes (Eugene,
OR, USA) and pluronic F-127 was purchased from Calbiochem
(Bad Soden, Germany). The protonophore carbonyl cyanide
m-chlorophenyl-hydrazone (CCCP) was obtained from Sigma.
HOE-694 was kindly provided by Hoechst AG (Frankfurt, Ger-
many).
Measurements of pH
LLC-PK1 cells were loaded with BCECF using the membrane-
permeable ester (BCECF-AM, 10 xmol/liter, dissolved in 0.1
g/liter pluronic F-I 27 in standard solution) at room temperature
for 29 2 mm (N = 31) in the dark. CCD segments were loaded
with BCECF-AM, 1 jmol/liter, at room temperature for 43 2
mm (N = 29) in the dark. Loaded LLC-PK1 cells or CCD
segments were excited at 488 and 436 nm using a filter wheel
(Physiologisches Institut, Universität Freiburg, Germany) rotating
at 10 Hz and a xenon-quartz lamp (XBO 75 W; Zeiss) as light
source. Fluorescence at 520 to 560 nm was detected with a single
photon counting tube (H3460-04; Hamamatsu, Herrsching, Ger-
many) and 10 consecutive data points were averaged yielding a
time resolution of 1 Hz. The autofluorescence and the system
noise was measured at both excitation wavelengths before loading
the cells in each experiment, and subtracted from the experimen-
tal BCECF fluorescence signals. An iris diaphragm allowed
reduction of the area of measurement to a single cell of the CCD
segments. In the CCD segments measurements of pH1 were taken
exclusively from the majority of cells, demonstrating a low fluo-
rescence typical for principal cells [23, 24]. For measurements of
pH in LLC-PK1 cells the diaphragm was restricted to cover
approximately 5 to 10 cells. The fluorescence ratio was recorded
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Fig. 1. Calibration curves for the BCECF-fluorescence ratio measure-
ments of pH1 in LLC-PK1 cells (•; ratio +4.99/0.99) and CCD cells (tx;
ratio + 4.73/0.84). Calibrations were done at given extracellular pH values
in the presence of 1 mol/liter of the protonophore CCCP (see Methods).
The calibration curve for the LLC-PK1 cells was obtained from 7
monolayers, that for CCD cells from 18 CCD segments. Mean values
SEM are given. The difference in the fluorescence ratios are due to the fact
that the experiments with LLC-PK1 cells and CCD cells were performed
at two different experimental systems.
after a 15-minute equilibration period in the continuously per-
fused bath. Experiments were controlled and data analyzed with
an AT-486 computer system and specific software (U. Fröbe,
Universität Freiburg, Germany).
Calibration of the BCECF fluorescence signal was done in
separate experiments with 7 LLC-PK1 monolayers and 18 CCD
segments using the protonophore CCCP (1 jxmol/liter) and
external pH values between 6.5 and 8.0 as described in detail [23].
These calibration curves are depicted in Figure 1. In this range the
dependence of the fluorescence ratio on the external pH was
linear and pH1 could be calculated from the equations shown in
Figure 1.
Statistics
Data are presented as fluorescence ratios (488/436 nm) in
Figures presenting original recordings or as mean values of
calculated pH1 values SEM in the summaries, with the number of
experiments given in parenthesis. A paired or unpaired t-test
(two-sided) was used where appropriate to test for the statistical
significance. For the paired comparison the pre- and post-exper-
imental controls values were averaged. A value for P 0.05 was
set as significance level.
RESULTS
pH of LLC-PK1 cells
In 48 measurements the pH1 of LLC-PK1 cells under control
conditions was 7.36 0.03. An inhibitor of the Na/H ex-
changer, HOE 694, did not significantly influence pH1 up to a
concentration of to jxmol/liter (pH1 was —0.01 0.01, N = 6);
at a concentration of 100 xmol/liter, however, it decreased pH1
slightly but significantly by 0.03 0.01 pH units (N = 6).
Moxonidine tested at a concentration of 10 xmol/Iiter also did not
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significantly influence the resting pH of LLC-PK1 cells (zpH1 was
—0.01 0.01, N = 7).
To examine whether HOE 694 and moxonidine would have an
effect when the Na17H exchange was stimulated, LLC-PK1 cells
were acidified by the addition of 20 mmol/liter propionate. As is
shown in Figure 2, the presence of propionate resulted in a
decrease in pH, that recovered slowly in the continued presence of
propionate, indicating the activity of a Nat'H exchanger. After
removal of propionate pH rapidly increased above the control
value before returning to the control pH,. In the series of 38 such
experiments pH declined from 7.36 0.04 to a minimum of
7.04 0.04. The recovery rate of pH, in the presence of
propionate (pH1/min) was analyzed by fitting a line by eye to the
increase in pH, during the first minute after reaching a minimum.
In these 38 experiments the average recovery rate of pH1 after the
initial maximal acidification in the presence of propionate was
0.21 0.03 pH units/mm. The original fluorescence recordings
shown in Figure 2 demonstrate the inhibitory effects of HOE 694
(1 iimol/liter) on the recovery of pH1 after the propionate induced
acidification. This recovery rate, that is, the activity of the Na/H
exchanger, was significantly and reversibly decreased with HOE
694. As shown in Figure 3, the recovery of pH1 was also reversibly
inhibited by moxonidine (10 imol/liter). On average HOE 694
and moxonidine decreased pH1/min by 35 10% in 9 experi-
ments and by 43 4% in 26 experiments, respectively (Fig. 6).
The effects were always compared to the averaged recovery rates
of the pre- and postexperimental controls.
In another series of experiments we examined whether the
effect of moxoriidine on the activity of the Na/H exchanger was
due to a direct inhibition of the exchanger or whether it involved
activation of the imidazoline receptor. In the presence of the
imidazoline antagonist idazoxan (10 j.tmol/liter), the inhibition of
the pH recovery by moxonidine was abolished. An example of
such an experiment is depicted in Figure 3 and the data are
summarized in Figure 6. In the presence of the a2 antagonist
yohimbine (10 j.tmol/liter), the effect of moxonidine was not
significantly altered (pH, recovery in 5 paired experiments, —2
8%). These data are also included in Figure 6.
pH of CCD cells
In 40 CCD cells the resting pH1 was 7.29 0.05. Amiloride at
a concentration of 1 mmol/liter, which inhibits Na/H exchange
maximally, significantly reduced the control pH, by 0.18 0.03
units (N = 9). Moxonidine (10 j.mol/liter) also reduced the basal
pH1 significantly by 0.08 0.03 units in 12 experiments. Both
effects were reversible upon removal of the inhibitors.
An acidification of CCD cells was achieved using the NH4
prepulse technique. Addition of NH4C1 (20 mmol/liter) increased
pH, maximally by 0.59 0.05 pH units, and upon removal of
NH4CI from the bath solution pH1 transiently decreased by 0.46
0.05 pH units (N = 29). The initial recovery rate of pH, after the
maximal acidification was 0.21 0.03 pH units/mm under control
conditions. Figure 4 depicts an original fluorescence recording as
an example for the effect of amiloride (1 mmol/liter) on this
recovery rate of pH1 after the NH4-induced acidification, that is,
activation of the Nat'H exchanger. Amiloride reduced the
recovery rate on average reversibly by 79 8% (N 10; Fig. 6).
Moxonidine (10 imol/liter) also inhibited this recovery rate as
shown in the original recording depicted in Figure 5. In 18 of such
experiments moxonidine inhibited the pH1 recovery significantly
by 45 6%. These data are summarized in Figure 6.
The involvement of imidazolin receptors in the observed effect
of moxonidine on the pH, recovery was examined again using the
imidazolin receptor antagonist idazoxan (10 mol/liter). Figure 5
demonstrates that the moxonidine induced inhibition of the pH,
recovery is also absent in rat CCD cells in the presence of this
antagonist. Figure 6 summarizes the effects of seven such exper-
iments. In the presence of the a2 antagonist yohimbine (10
mol/liter), the effect of moxonidine was not significantly altered
(L pH, recovery in 4 paired experiments, —1 1%). These data
are also included in Figure 6.
DISCUSSION
In animal studies natriuresis has been found after the admin-
istration of guanidinium compounds, which have a high affinity to
imidazoline preferring sites [251. The opposite effect, that is, Na
retention and also an increased free water clearance, was seen
after stimulation of a2-adrenoceptors [26]. Whereas the latter
probably is due to an interference with the vasopressin dependent
regulation of Na and water reabsorption in the collecting duct
[16, 27], guanidinium compounds that bind to imidazoline recep-
tors most likely inhibit Na/L-P exchange in the kidney [20].
The experiments reported here from proximal LLC-PK1 cells
and from rat CCD demonstrate that moxonidine indeed inhibits
Na/H exchange via an activation of imidazolin receptors.
Activity of the Na/H exchanger
The experimental conditions chosen, that is, absence of
HCO31CO2, reduce the involvement of transport systems in the
cellular pH homeostasis almost exclusively to the Na/H ex-
change. Thus, the recovery of pH, after strong cellular acidifica-
tion by propionate or NH4 is mostly due to the activity of the
Na/H exchanger. Therefore, the slope of the pH1 recovery can
be used to estimate the transport activity of this system. In both
cell types studied, LLC-PK1 cells and principal cells of rat CCD,
the basal pH was around 7.3. Inhibition of the Na/H exchanger
with HOE-694, an inhibitor of the Na/H exchanger that is the
most specific for the NHE-1 isoform [281, acidified pH1 in
E
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Fig. 2. Original recording of the BCECF-tluorescence ratio of LLC-PK1
cells. Effect of HOE-694 (1 j.mol/liter) on the recovery of pH1 from an
acidification induced by 20 mmol/liter propionate. Lines were freely fitted
to the slopes of the fluorescence increase to estimate Na/H activity.
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Fig. 3. Original recording of the BCECF-
fluorescence ratio of LLC-PK1 cells. Effect of
moxonidine (10 imol/1iter) in the absence and
presence of idazoxan (10 smol/1iter) on the
recovery of pH1 from an acidification induced
by 20 mmollliter propionate. Lines were freely
fitted to the slopes of the fluorescence increase
to estimate Na/H activity.
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Fig. 4. Original recording of the BCECF-fluorescence ratio of a CCD
cell. Effect of amiloride (1 mmol/liter) on the recovery of pH, from an
acidification induced after removal of 20 mmol/liter NH4. Lines were
freely fitted to the slopes of the fluorescence increase to estimate Na/H
activity.
LLC-PK1 cells only in high concentrations (100 smol/liter).
Amiloride, tested at a concentration of 1 mmol/liter, at which it
should completely inhibit the NaIH exchanger, also only
slightly reduced pH, in the rat CCD. Recently we have reported
that HOE-694 acidified basal pH, of rat CCD cells moderately at
10 ,irmollliter [22]. These data again indicate that the Na/H
activity is low in rat CCD under resting conditions. In the proximal
tubule, in addition to the basolateral NHE- 1 isoform of the
Na/H exchanger a NHE-2 isoform is present in the luminal
membrane, and both isoforms are also present in LLC-PK1 cells
with polarized distribution [29]. Whereas the NHE1-isoform,
responsible for the pH regulation of proximal tubule cells, is
probably mostly inactive at normal pH,, the NHE-2 isoform,
responsible for most of the Na reabsorption in this tubule
segment, is probably active. The differences in the affinity of
HOE-694 to these two isoforms of the exchanger most likely
explain the small effect of this drug on the resting pH, observed in
the present study in LLC-PK1 cells. A significant acidification
indicating inhibition of the Na/H exchangers was achieved only
at high concentrations, which are needed to inhibit both isoforms
of the exchanger. Generally the activity of the Na/H exchanger
is stimulated when pH, falls [30]. This was demonstrated for
Moxonidine —
— NH4
Idazoxan —
Fig. 5. Original recording of the BCECF-fluorescence ratio of a CCD
cell. Effect of moxonidine (10 .rmol/liter) in the absence and presence of
idazoxan (10 mol/liter) on the recovery of pH from an acidification
induced after removal of 20 mmol/liter NH4. Lines were freely fitted to
the slopes of the fluorescence increase to estimate Nat'H activity.
principal cells of rabbit CCD [24] and also recently by us for
principal cells of rat CCD [22]. Thus, when the cells were acidified
by either proprionate (LLC-PK1 cells) or NH4 removal (CCD
cells) the activity of the Na/H was increased, which resulted in
a recovery from the acidification (Figs. 2 and 4). The fact that this
recovery of pH, was due to increased exchanger activity was also
evident from the fact that pH, turned even more alkaline than the
control value when the proprionate was washed off (Fig. 2).
Therefore, the rate of pH, recovery approximates the activity of
the Nat'H exchanger.
Influence of moxonidine on Na/H exchange
For a2-adrenergic agonists such as norepinephrine, a stimula-
tion of the Na/H exchanger present in the brush border
membrane of the proximal tubule of rabbit was shown [14] to be
consistent with the generally observed antinatriuretic response to
catecholamines. Regulation of the exchanger activity by adrener-
gic substances appears, however, to also involve an inhibitory
mechanism [15]. In the latter study a pertussis toxin sensitive
stimulation of Na/H activity could be inhibited with guanabenz.
The authors concluded that the exchanger might, in addition to its
a2-adrenoceptor mediated activation, be inhibited by a direct
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Fig. 6. Summary of the effects of HOE-694 (1
mol/liter, LLC-PK1 cells), of amiloride (1
mmol/liter, CCD cells) and of moxonidine (10
LmoIJ1iter) in the absence and presence of
idazoxan (10 .tmol/liter) or yohimbine (10
tmol/liter) on the recovery of pH1 after
acidification. Acidification was achieved by the
addition of 20 mmol/Iiter propionate (LLC-PK1
cells) or by the NH4 prepulse technique (CCD
cells). Data are presented as mean values
SEM of the control recovery rates, with the
number of observations given in brackets.
*Statistically significant differences to the
respective controls; #statistically significant
differences to moxonidine alone.
interaction of this guanidinium compound with the exchanger. In
a number of different preparations similar observations have been
made with other guanidinium derivatives, which have potent
antihypertensive properties in humans [19, 31]. Tn the latter study
it was shown that various guanidinium derivatives bind directly to
the Na/H exchanger, thereby inhibiting its activity. This binding
site is, however, different from the amiloride binding site. From
Na uptake measurements and recordings of the pH1 in rabbit
proximal tubules it was suggested that imidazoline derivatives
inhibit Na/H exchange by as yet unknown mechanisms, but
include binding to imidazoline receptors and signal transduction
via intracellular second messengers [20].
The results presented in our study clearly demonstrate that one
of the agonists for the imidazoline I receptor known so far,
moxonidine, reduces the activity of the Na/H exchanger both in
LLC-PK1 cells, which have properties of the proximal tubule, and
in rat CCD cells. Even at a concentration of 10 mol/liter this
drug reduced the activity of the exchanger by about 50%. This
inhibition appears to be more specific for the NHE-1 isoform of
the exchanger, as moxonodine had no effect on basal pH in
LLC-PK1 cells derived from the proximal tubule. Under basal
conditions probably mostly the NHE-2 isoform is active and the
NHE-1 isoform is active only after cellular acidification [29].
Furthermore, the fact that moxonidine also inhibited the Na/H
exchanger in the CCD supports this interpretation, since in this
nephron segment the Na/H exchanger is present in the baso-
lateral membrane [32], which generally contains the NHE-1
isoform as the "housekeeping" pH regulating system. In both cell
types studied the observed inhibition of Na/H exchange by
moxonidine is apparantly mediated via binding of the agonist to
imidazoline-specific binding sites, because the effects could be
almost completely inhibited by the receptor anatgonist idazoxan,
but not by the a2-adrenoceptor antagonist yohimbine. These
findings are consistent with the observed inhibition of the natri-
uretic and diuretic effects of moxonidine by idazoxan in clearance
experiments in the rat [25].
In conclusion, we demonstrated a reversible inhibition of the
Na7H exchanger both in proximal tubular cells (LLC-PK1) and
the cortical collecting duct by the imidazoline receptor agonist
moxonidine, which could be inhibited by the imidazolin receptor
antagonist idazoxan, but not an a2-adrenoceptor antagonist. This
effect of moxonidine on Na/H exchange comparable to that of
other guanidinium-derived antihypertensive drugs also may be
relevant to understand its therapeutic action in hypertensive
patients.
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